<p>Moleculin Biotech Inc. has announced a Special Meeting of Stockholders to be held on February 5, 2026. Among the proposals to be voted on are the Nasdaq Proposal, a Name Change Proposal, and an Adjournment Proposal. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-038449), on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

MBRX

<p>Moleculin Biotech Inc. will hold a Special Meeting of Stockholders on February 5, 2026, to vote on proposals including the Nasdaq Proposal, Name Change Proposal, and Adjournment Proposal. The announcement was originally published via EDGAR by Moleculin Biotech Inc. on December 19, 2025.</p>

Moleculin Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting